| Cash Flow | 2025-08-31 | 2025-05-31 | 2024-11-30 | 2024-08-31 |
|---|---|---|---|---|
| Impairment of equity method investments | - | - | 2,400 | 2,100 |
| Unrealized net (gain) loss on securities measured at fair value | - | - | -2,500 | -2,500 |
| Net income (loss) | 1,009,900 | 523,800 | 339,500 | -289,600 |
| Goodwill impairment | 0 | - | 2,250,000 | 2,250,000 |
| Assets held for sale impairment and related expenses | - | 52,100 | - | - |
| Asset impairment and related expenses | 52,100 | - | - | - |
| Deferred tax provision (benefit) | 277,600 | 34,000 | -184,200 | -178,500 |
| Depreciation | 207,900 | 105,200 | 339,800 | 220,800 |
| Stock-based compensation | 32,100 | 10,400 | 60,700 | 41,000 |
| Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings | - | - | 25,800 | 1,900 |
| Noncash lease expense | 62,600 | 31,000 | 85,200 | 57,700 |
| Net gain on conversion and exchange to exchangeable shares | - | - | - | 83,300 |
| Net gain in connection with exchangeable shares | 0 | 0 | 44,700 | - |
| Accounts receivable | -72,200 | 73,900 | 7,700 | 40,600 |
| Inventories | 48,300 | 20,800 | 54,200 | -14,700 |
| Prepaid expenses and other current assets | 56,800 | 25,800 | 47,200 | 77,700 |
| Accounts payable | 53,000 | 36,700 | 117,400 | 134,500 |
| Deferred revenue | - | - | - | 9,700 |
| Contract liabilities | -50,400 | 6,300 | - | - |
| Other accrued expenses and liabilities | -57,000 | -92,300 | -117,400 | -55,400 |
| Other | -65,600 | 50,500 | -158,800 | -133,700 |
| Total adjustments | 479,400 | 113,400 | 2,218,000 | 2,161,900 |
| Net cash provided by (used in) operating activities | 1,489,300 | 637,200 | 2,557,500 | 1,872,300 |
| Purchase of property, plant, and equipment | 410,100 | 192,800 | 931,500 | 703,100 |
| Purchase of business, net of cash acquired | 0 | - | 158,700 | 158,300 |
| Investments in equity method investees and securities | 7,000 | 7,000 | 31,100 | 19,000 |
| Proceeds from sale of assets | 30,800 | 0 | 34,800 | 32,800 |
| Proceeds from sale of business | 851,100 | 3,700 | 0 | 0 |
| Other investing activities | 0 | 0 | 11,700 | 10,000 |
| Net cash provided by (used in) investing activities | 464,800 | -196,100 | -1,098,200 | -857,600 |
| Proceeds from issuance of long-term debt | 499,100 | 499,100 | 0 | 0 |
| Principal payments of long-term debt | 902,100 | 1,000 | 956,000 | 554,300 |
| Net proceeds from (repayments of) short-term borrowings | -554,200 | -429,200 | 648,700 | 266,700 |
| Dividends paid | 361,100 | 182,200 | 551,300 | 368,600 |
| Purchases of treasury stock | 604,000 | 306,100 | 668,100 | 449,200 |
| Proceeds from shares issued under equity compensation plans | 3,100 | 5,300 | 66,200 | 48,400 |
| Payments of minimum tax withholdings on stock-based payment awards | 9,500 | 9,400 | 13,800 | 13,800 |
| Payments of debt issuance, debt extinguishment, and other financing costs | 5,400 | 5,200 | 100 | 0 |
| Purchase of noncontrolling interest | - | - | 16,200 | 32,500 |
| Distributions to noncontrolling interests | 17,500 | 7,500 | 47,500 | - |
| Payment of contingent consideration | 1,500 | 1,400 | 700 | 700 |
| Net cash provided by (used in) financing activities | -1,953,100 | -437,600 | -1,538,800 | -1,104,000 |
| Effect of exchange rate changes on cash and cash equivalents | 2,900 | 2,300 | 800 | 1,500 |
| Net increase (decrease) in cash and cash equivalents | 3,900 | 5,800 | -78,700 | -87,800 |
| Cash and cash equivalents at beginning of period | 68,100 | 68,100 | 152,400 | 152,400 |
| Cash and cash equivalents at end of period | 72,000 | 73,900 | 73,700 | 64,600 |
CONSTELLATION BRANDS, INC. (STZ)
CONSTELLATION BRANDS, INC. (STZ)